Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 30 Records) |
| Query Trace: Arthritis and FCGR2A[original query] |
|---|
| Studies on the association of Fc gamma receptor IIA, IIB, IIIA and IIIB polymorphisms with rheumatoid arthritis in the Japanese: evidence for a genetic interaction between HLA-DRB1 and FCGR3A. Genes and immunity 2002 Dec 3 (8): 488-93. Kyogoku C, Tsuchiya N, Matsuta K, Tokunaga |
| Genetic risk factors for infection in patients with early rheumatoid arthritis. Genes and immunity 2004 Dec 5 (8): 641-7. Hughes L B, Criswell L A, Beasley T M, Edberg J C, Kimberly R P, Moreland L W, Seldin M F, Bridges S |
| The influence of genetic variation in the HLA-DRB1 and LTA-TNF regions on the response to treatment of early rheumatoid arthritis with methotrexate or etanercept. Arthritis and rheumatism 2004 Sep 50 (9): 2750-6. Criswell Lindsey A, Lum Raymond F, Turner Kevin N, Woehl Blanche, Zhu Yuanqing, Wang Jinyi, Tiwari Hemant K, Edberg Jeffrey C, Kimberly Robert P, Moreland Larry W, Seldin Michael F, Bridges S Lou |
| Analysis of Fcgamma receptor haplotypes in rheumatoid arthritis: FCGR3A remains a major susceptibility gene at this locus, with an additional contribution from FCGR3B. Arthritis research & therapy 2006 8 (1): R5. Morgan Ann W, Barrett Jennifer H, Griffiths Bridget, Subramanian Deepak, Robinson Jim I, Keyte Viki H, Ali Manir, Jones Elizabeth A, Old Robert W, Ponchel Frederique, Boylston Arthur W, Situnayake R Deva, Markham Alexander F, Emery Paul, Isaacs John |
| A functional variant of Fcgamma receptor IIIA is associated with rheumatoid arthritis in individuals who are positive for anti-glucose-6-phosphate isomerase antibodies. Arthritis research & therapy 2005 7 (6): R1183-8. Matsumoto Isao, Zhang Hua, Muraki Yoshifumi, Hayashi Taichi, Yasukochi Takanori, Kori Yuko, Goto Daisuke, Ito Satoshi, Tsutsumi Akito, Sumida Takayu |
| Influence of variants of Fc gamma receptors IIA and IIIA on the American College of Rheumatology and European League Against Rheumatism responses to anti-tumour necrosis factor alpha therapy in rheumatoid arthritis. Annals of the rheumatic diseases 2009 Oct 68 (10): 1547-52. Cañete J D, Suárez B, Hernández M V, Sanmartí R, Rego I, Celis R, Moll C, Pinto J A, Blanco F J, Lozano |
| Associations between FCGR3A polymorphisms and susceptibility to rheumatoid arthritis: a metaanalysis. The Journal of rheumatology 2008 Nov 35 (11): 2129-35. Lee Young Ho, Ji Jong Dae, Song Gwan G |
| Genetic variants at CD28, PRDM1 and CD2/CD58 are associated with rheumatoid arthritis risk. Nature genetics 2009 Dec 41 (12): 1313-8. Raychaudhuri Soumya, Thomson Brian P, Remmers Elaine F, Eyre Stephen, Hinks Anne, Guiducci Candace, Catanese Joseph J, Xie Gang, Stahl Eli A, Chen Robert, Alfredsson Lars, Amos Christopher I, Ardlie Kristin G, , Barton Anne, Bowes John, Burtt Noel P, Chang Monica, Coblyn Jonathan, Costenbader Karen H, Criswell Lindsey A, Crusius J Bart A, Cui Jing, De Jager Phillip L, Ding Bo, Emery Paul, Flynn Edward, Harrison Pille, Hocking Lynne J, Huizinga Tom W J, Kastner Daniel L, Ke Xiayi, Kurreeman Fina A S, Lee Annette T, Liu Xiangdong, Li Yonghong, Martin Paul, Morgan Ann W, Padyukov Leonid, Reid David M, Seielstad Mark, Seldin Michael F, Shadick Nancy A, Steer Sophia, Tak Paul P, Thomson Wendy, van der Helm-van Mil Annette H M, van der Horst-Bruinsma Irene E, Weinblatt Michael E, Wilson Anthony G, Wolbink Gert Jan, Wordsworth Paul, , Altshuler David, Karlson Elizabeth W, Toes Rene E M, de Vries Niek, Begovich Ann B, Siminovitch Katherine A, Worthington Jane, Klareskog Lars, Gregersen Peter K, Daly Mark J, Plenge Robert |
| Association of FcgR2a, but not FcgR3a, with inflammatory bowel diseases across three Caucasian populations. Inflammatory bowel diseases 2010 Dec 16 (12): 2080-9. Weersma Rinse K, Crusius J Bart A, Roberts Rebecca L, Koeleman Bobby P C, Palomino-Morales Rogelio, Wolfkamp Simone, Hollis-Moffatt Jade E, Festen Eleonora A M, Meisneris Sander, Heijmans Roel, Noble Colin L, Gearry Richard B, Barclay Murrary L, Gómez-Garcia María, Lopez-Nevot Miguel A, Nieto Antonio, Rodrigo Luis, Radstake Timothy R D J, van Bodegraven Adriaan A, Wijmenga Cisca, Merriman Tony R, Stokkers Pieter C F, Peña A Salvador, Martín Javier, Alizadeh Behrooz |
| A trans-ethnic genetic study of rheumatoid arthritis identified FCGR2A as a candidate common risk factor in Japanese and European populations. Modern rheumatology / the Japan Rheumatism Association 2012 Feb 22 (1): 52-8. Meziani Roubila, Yamada Ryo, Takahashi Meiko, Ohigashi Kenei, Morinobu Akio, Terao Chikashi, Hiratani Hitomi, Ohmura Koichiro, Yamaguchi Masao, Nomura Takashi, Vasilescu Alexandre, Kokubo Miki, Renault Victor, Hirosawa Katsura, Ratanajaraya Chanavee, Heath Simon, Mimori Tsuneyo, Sakaguchi Shimon, Lathrop Mark, Melchers Inga, Kumagai Shunichi, Matsuda Fumihi |
| Replicated associations of TNFAIP3, TNIP1 and ETS1 with systemic lupus erythematosus in a southwestern Chinese population. Arthritis research & therapy 2011 13 (6): R186. Zhong Hua, Li Xiao-lan, Li Ming, Hao Li-xia, Chen Rong-wei, Xiang Kun, Qi Xue-bin, Ma Runlin Z, Su Bi |
| FCGR2A/CD32A and FCGR3A/CD16A variants and EULAR response to tumor necrosis factor-a blockers in psoriatic arthritis: a longitudinal study with 6 months of followup. The Journal of rheumatology 2012 May 39 (5): 1035-41. Ramírez Julio, Fernández-Sueiro José Luis, López-Mejías Raquel, Montilla Carlos, Arias Maite, Moll Concepción, Alsina Mercé, Sanmarti Raimon, Lozano Francisco, Cañete Juan |
| Investigation of Caucasian rheumatoid arthritis susceptibility loci in African patients with the same disease. Arthritis research & therapy 2012 14 (6): R239. Viatte Sebastien, Flynn Edward, Lunt Mark, Barnes Joanne, Singwe-Ngandeu Madeleine, Bas Sylvette, Barton Anne, Gabay C |
| Fc?RIIa and Fc?RIIIb polymorphisms and associations with clinical manifestations in systemic lupus erythematosus patients. Autoimmunity 2014 Nov 47 (7): 451-8. Vigato-Ferreira Isabel Cristina Costa, Toller-Kawahisa Juliana Escher, Pancoto João Alexandre Trés, Mendes-Junior Celso Teixeira, Martinez Edson Zangiacomi, Donadi Eduardo Antônio, Louzada-Júnior Paulo, Del Lama José Eduardo Cavalcanti, Marzocchi-Machado Cleni Ma |
| Genetic variation in immunoglobulin G receptor affects survival after lung transplantation. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2014 Jul 14 (7): 1672-7. Ruttens D, Verleden S E, Goeminne P C, Vandermeulen E, Wauters E, Cox B, Vos R, Van Raemdonck D E, Lambrechts D, Vanaudenaerde B M, Verleden G |
| Association of FCGR2A with the response to infliximab treatment of patients with rheumatoid arthritis. Pharmacogenetics and genomics 2014 May 24 (5): 238-45. Montes Ariana, Perez-Pampin Eva, Narváez Javier, Cañete Juan D, Navarro-Sarabia Federico, Moreira Virginia, Fernández-Nebro Antonio, Del Carmen Ordóñez María, de la Serna Arturo R, Magallares Berta, Vasilopoulos Yiannis, Sarafidou Theologia, Caliz Rafael, Ferrer Miguel Angel, Joven Beatriz, Carreira Patricia, Gómez-Reino Juan J, Gonzalez Anton |
| FCGR2A, FCGR3A, FCGR3B polymorphisms and susceptibility to rheumatoid arthritis: a meta-analysis. Clinical and experimental rheumatology 2015 Aug . Lee Young Ho, Bae Sang-Cheol, Song Gwan G |
| Association analysis of copy numbers of FC-gamma receptor genes for rheumatoid arthritis and other immune-mediated phenotypes. European journal of human genetics : EJHG 2015 May . Franke Lude, El Bannoudi Hanane, Jansen Diahann T S L, Kok Klaas, Trynka Gosia, Diogo Dorothee, Swertz Morris, Fransen Karin, Knevel Rachel, Gutierrez-Achury Javier, Ärlestig Lisbeth, Greenberg Jeffrey D, Kremer Joel, Pappas Dimitrios A, Kanterakis Alexandros, Weersma Rinse K, van der Helm-van Mil Annette H M, Guryev Viktor, Rantapää-Dahlqvist Solbritt, Gregersen Peter K, Plenge Robert M, Wijmenga Cisca, Huizinga Tom W-J, Ioan-Facsinay Andreea, Toes Rene E M, Zhernakova Alexand |
| Variation at FCGR2A and functionally related genes is associated with the response to anti-TNF therapy in rheumatoid arthritis. PloS one 2015 10 (4): e0122088. Avila-Pedretti Gabriela, Tornero Jesús, Fernández-Nebro Antonio, Blanco Francisco, González-Alvaro Isidoro, Cañete Juan D, Maymó Joan, Alperiz Mercedes, Fernández-Gutiérrez Benjamín, Olivé Alex, Corominas Héctor, Erra Alba, Aterido Adrià, López Lasanta María, Tortosa Raül, Julià Antonio, Marsal Sa |
| FcGR genetic polymorphisms and the response to adalimumab in patients with rheumatoid arthritis. Pharmacogenomics 2015 16 (4): 373-81. Dávila-Fajardo Cristina Lucía, van der Straaten Tahar, Baak-Pablo Rene, Medarde Caballero Catalina, Cabeza Barrera Jose, Huizinga Tom W, Guchelaar Henk-Jan, Swen Jesse |
| FCGR polymorphisms in the treatment of rheumatoid arthritis with Fc-containing TNF inhibitors. Pharmacogenomics 2015 16 (4): 333-45. Montes Ariana, Perez-Pampin Eva, Joven Beatriz, Carreira Patricia, Fernández-Nebro Antonio, Del Carmen Ordóñez María, Navarro-Sarabia Federico, Moreira Virginia, Vasilopoulos Yiannis, Sarafidou Theologia, Caliz Rafael, Ferrer Miguel Angel, Cañete Juan D, de la Serna Arturo R, Magallares Berta, Narváez Javier, Gómez-Reino Juan J, Gonzalez Anton |
| Associations between PTPRC rs10919563 A/G and FCGR2A R131H polymorphisms and responsiveness to TNF blockers in rheumatoid arthritis: a meta-analysis. Rheumatology international 2016 Apr . Lee Young Ho, Bae Sang-Che |
| Association of FCGR2A rs1801274 polymorphism with susceptibility to autoimmune diseases: A meta-analysis. Oncotarget 2016 Jun . Zhang Chang'e, Wang Wenju, Zhang Hong'e, Wei Lulu, Guo Shupi |
| Systematic review and meta-analysis: pharmacogenetics of anti-TNF treatment response in rheumatoid arthritis. The pharmacogenomics journal 2017 Jun . Bek S, Bojesen A B, Nielsen J V, Sode J, Bank S, Vogel U, Andersen |
| FCGR2A/FCGR3A Gene Polymorphisms and Clinical Variables as Predictors of Response to Tocilizumab and Rituximab in Patients With Rheumatoid Arthritis. Journal of clinical pharmacology 2019 Apr 59 (4): 517-531. Jiménez Morales Alberto, Maldonado-Montoro Mar, Martínez de la Plata Juan Enrique, Pérez Ramírez Cristina, Daddaoua Abdelali, Alarcón Payer Carolina, Expósito Ruiz Manuela, García Collado Carl |
| Influence of the FCGR2A rs1801274 and FCGR3A rs396991 Polymorphisms on Response to Abatacept in Patients with Rheumatoid Arthritis. Journal of personalized medicine 2021 Jun 11 (6): . Márquez Pete Noelia, Maldonado Montoro María Del Mar, Pérez Ramírez Cristina, Martínez Martínez Fernando, Martínez de la Plata Juan Enrique, Daddaoua Abdelali, Jiménez Morales Alber |
| Exploring pharmacogenetic variants for predicting response to anti-TNF therapy in autoimmune diseases: a meta-analysis. Pharmacogenomics 2021 4 22 (7): 435-445. Antonatos Charalabos, Stavrou Eleana F, Evangelou Evangelos, Vasilopoulos Yiann |
| Genetic Biomarkers as Predictors of Response to Tocilizumab in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis. Genes 2022 Jul 13 (7): . Janahiraman Sivakami, Too Chun Lai, Lee Kai Wei, Shahril Nor Shuhaila, Leong Chee O |
| Impact of FCGR2A R131H, FCGR3A F158V and FCGR3B NA1/NA2 polymorphisms on response to fc-containing TNF inhibitors in Tunisian rheumatoid arthritis patients. Drug metabolism and personalized therapy 2023 3 . Ines Mahmoud, Myriam Moalla, Aicha Ben Tekaya, Selma Bouden, Leila Rouached, Rawdha Tekaya, Olfa Saidane, Yousr Gorji, Mohamed Elleuch, Ahmed Laatar, Wafa Hamdi, Leila Abdelmoula, Imen Sf |
| Impact of FCGR2A rs1801274 and IL-6R rs2228145 polymorphisms on tocilizumab response in the Iranian population with severe COVID-19. BMC infectious diseases 2024 10 24 (1): 1168. Nastaran Injinari, Samira Asadollahi, Fateme Sefid, Maedeh Arshadi, Saeedeh Sadat Hosseini, Hamed Ghoshouni, Fatemeh Soltani, Nasim Namiranian, Mohammad Hasan Sheikhha, Fatemeh Aghaeimeybo |
- Page last reviewed:Feb 1, 2024
- Content source: